IRCT20200506047323N6招募中3 期
The efficacy and safety of Ivermectin in patients with COVID-19: a randomized clinical trial
Bandare-abbas University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 no limit（—）
- 性别
- All
入选标准
- •Age =20 years old
- •Weight =35 kg
- •Positive polymerase chain reaction (PCR) test for COVID-19
- •Non-hospitalized mild as well as hospitalized moderate patients
- •Signed informed consent voluntarily and knowingly
排除标准
- •Underlying diseases (AIDS, asthma, severe liver and kidney disease)
- •History of Loiasis
- •History of drug allergy to Ivermectin
- •Use of anticoagulants (e.g. warfarin) and ACE inhibitors (e.g. captopril)
- •Pregnancy or breastfeeding
研究者
相似试验
已完成
1 期
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49
已完成
2 期
Evaluating the effect of Ivermectin on covid 19 patientsCOVID 19.Corona virus infection, unspecifiedU07.1IRCT20200404046937N4Ahvaz University of Medical Sciences60
招募中
2 期
A randomized control trial to assess the efficacy and safety of ivermectin in the treatment of mild to moderate COVID 19 patientsCOVID-19SLCTR/2021/020Dr Ananda Wijewickrama
招募中
3 期
Ivermectin in Prevention and Treatment of COVID-19TCTR20210929002Faculty of Medicine Siriraj Hospital, Mahidol university1,000
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375